The relationship of salivary testosterone and male sexual dysfunction in opioid-associated androgen deficiency (OPIAD)

References

• Jovey RD, Ennis J, Gardner-Nix J, et al. Use of opioid analgesics for the treatment of chronic noncancer pain – a consensus statement and guidelines from the Canadian Pain Society, 2002. Pain Res Manag 2003;8:3A–28A
   PubMedGoogle Scholar
• Brown RT, Zuelsdorff M, Fleming M. Adverse effects and cognitive function among primary care patients taking opioids for chronic nonmalignant pain. J Opioid Manag 2006;2:137–46
   PubMedGoogle Scholar
• Abs R, Verhelst J, Maeyaert J, et al. Endocrine consequences of long-term intrathecal administration of opioids. J Clin Endocrinol Metab 2000;85:2215–22
   PubMed Web of Science ®Google Scholar
• Paice JA, Penn RD, Ryan WG. Altered sexual function and decreased testosterone in patients receiving intraspinal opioids. J Pain Symptom Manage 1994;9:126–31
   PubMed Web of Science ®Google Scholar
• Lunenfeld B, Mskhalaya G, Zitzmann M, et al. Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men. Aging Male 2015;18:5–15
   PubMed Web of Science ®Google Scholar
• Wang C, Nieschlag E, Swerdloff RS, et al. ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male 2009;12:5–12
   PubMed Web of Science ®Google Scholar
• Morales AJ, Haubrich RH, Hwang JY, et al. The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women. Clin Endocrinol (Oxf) 1998;49:421–32
   PubMed Web of Science ®Google Scholar
• Smith HS, Elliott JA. Opioid-induced androgen deficiency (OPIAD). Pain Phys 2012;15:ES145–56
   PubMed Web of Science ®Google Scholar
• Niv D, Devor M, European Federation of IC. Position paper of the European Federation of IASP Chapters (EFIC) on the subject of pain management. Eur J Pain 2007;11:487–9
   PubMed Web of Science ®Google Scholar
• Finch PM, Roberts LJ, Price L, et al. Hypogonadism in patients treated with intrathecal morphine. Clin J Pain 2000;16:251–4
   PubMed Web of Science ®Google Scholar
• Kohler TS, McVary KT. The relationship between erectile dysfunction and lower urinary tract symptoms and the role of phosphodiesterase type 5 inhibitors. Eur Urol 2009;55:38–48
   PubMed Web of Science ®Google Scholar
• Gheorghiu I, Moshyk A, Lepage R, et al. When is bioavailable testosterone a redundant test in the diagnosis of hypogonadism in men? Clin Biochem 2005;38:813–18
   PubMed Web of Science ®Google Scholar
• Anantharaman P, Schmidt RJ. Sexual function in chronic kidney disease. Adv Chronic Kidney Dis 2007;14:119–25
   PubMed Web of Science ®Google Scholar
• Kaplan AL, Hu JC, Morgentaler A, et al. Testosterone therapy in men with prostate cancer. Eur Urol 2016;69:894–903
   PubMed Web of Science ®Google Scholar
• Morgentaler A. Controversies and advances with testosterone therapy: a 40-year perspective. Urology 2016;89:27–32
   PubMed Web of Science ®Google Scholar
• Katz N, Mazer NA. The impact of opioids on the endocrine system. Clin J Pain 2009;25:170–5
   PubMed Web of Science ®Google Scholar
• Cardoso EM, Contreras LN, Tumilasci EG, et al. Salivary testosterone for the diagnosis of androgen deficiency in end-stage renal disease. Nephrol Dial Transplant 2011;26:677–83
   PubMed Web of Science ®Google Scholar
• Groschl M. Current status of salivary hormone analysis. Clin Chem 2008;54:1759–69
   PubMed Web of Science ®Google Scholar
• Snyder PJ. Might testosterone actually reduce mortality? J Clin Endocrinol Metab 2008;93:32–3
   PubMed Web of Science ®Google Scholar
• Dunn JF, Nisula BC, Rodbard D. Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J Clin Endocrinol Metab 1981;53:58–68
   PubMed Web of Science ®Google Scholar
• Morley JE, Perry HM, 3rd, Patrick P, et al. Validation of salivary testosterone as a screening test for male hypogonadism. Aging Male 2006;9:165–9
   PubMed Web of Science ®Google Scholar
• Arregger AL, Contreras LN, Tumilasci OR, et al. Salivary testosterone: a reliable approach to the diagnosis of male hypogonadism. Clin Endocrinol (Oxf) 2007;67:656–62
   PubMed Web of Science ®Google Scholar
• Cardenas DD, Turner JA, Warms CA, et al. Classification of chronic pain associated with spinal cord injuries. Arch Phys Med Rehabil 2002;83:1708–14
   PubMed Web of Science ®Google Scholar
• Hatzichristou D, Rosen RC, Derogatis LR, et al. Recommendations for the clinical evaluation of men and women with sexual dysfunction. J Sex Med 2010;7:337–48
   PubMed Web of Science ®Google Scholar
• Ghanem HM, Salonia A, Martin-Morales A. SOP: physical examination and laboratory testing for men with erectile dysfunction. J Sex Med 2013;10:108–10
   PubMed Web of Science ®Google Scholar
• Kobori Y, Koh E, Sugimoto K, et al. The relationship of serum and salivary cortisol levels to male sexual dysfunction as measured by the International Index of Erectile Function. Int J Impot Res 2009;21:207–12
   PubMed Web of Science ®Google Scholar
• Moisey R, Swinburne J, Orme S. Serum testosterone and bioavailable testosterone correlate with age and body size in hypogonadal men treated with testosterone undecanoate (1000 mg IM-Nebido). Clin Endocrinol (Oxf) 2008;69:642–7
   PubMed Web of Science ®Google Scholar
• Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666–72
   PubMed Web of Science ®Google Scholar
• Yeap BB, Alfonso H, Chubb SA, et al. Reference ranges and determinants of testosterone, dihydrotestosterone, and estradiol levels measured using liquid chromatography–tandem mass spectrometry in a population-based cohort of older men. J Clin Endocrinol Metab 2012;97:4030–9
   PubMed Web of Science ®Google Scholar
• Rajagopal A, Vassilopoulou-Sellin R, Palmer JL, et al. Hypogonadism and sexual dysfunction in male cancer survivors receiving chronic opioid therapy. J Pain Symptom Manage 2003;26:1055–61
   PubMed Web of Science ®Google Scholar
• Ellison PT, Bribiescas RG, Bentley GR, et al. Population variation in age-related decline in male salivary testosterone. Hum Reprod 2002;17:3251–3
   PubMed Web of Science ®Google Scholar
• Nahoul K, Roger M. Age-related decline of plasma bioavailable testosterone in adult men. J Steroid Biochem 1990;35:293–9
   PubMedGoogle Scholar
• Matsumoto AM. Andropause: clinical implications of the decline in serum testosterone levels with aging in men. J Gerontol A Biol Sci Med Sci 2002;57:M76–99
   PubMed Web of Science ®Google Scholar
• Harman SM, Metter EJ, Tobin JD, et al. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 2001;86:724–31
   PubMed Web of Science ®Google Scholar
• Gray A, Feldman HA, McKinlay JB, et al. Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab 1991;73:1016–25
   PubMed Web of Science ®Google Scholar
• Aversa A, Morgentaler A. The practical management of testosterone deficiency in men. Nat Rev Urol 2015;12:641–50
   PubMed Web of Science ®Google Scholar
• Corona G, Mannucci E, Ricca V, et al. The age-related decline of testosterone is associated with different specific symptoms and signs in patients with sexual dysfunction. Int J Androl 2009;32:720–8
   PubMedGoogle Scholar
• Rabijewski M, Papierska L, Kozakowski J, et al. The high prevalence of testosterone deficiency in population of Polish men over 65 years with erectile dysfunctions. Aging Male 2012;15:258–62
   PubMed Web of Science ®Google Scholar
• Ellison PT, Panter-Brick C. Salivary testosterone levels among Tamang and Kami males of central Nepal. Hum Biol 1996;68:955–65
   PubMed Web of Science ®Google Scholar
• Bribiescas RG. Testosterone levels among Aché hunter-gatherer men: a functional interpretation of population variation among adult males. Hum Nat 1996;7:163–88
   PubMed Web of Science ®Google Scholar
• Bribiescas RG. An evolutionary and life history perspective on human male reproductive senescence. Ann N Y Acad Sci 2010;1204:54–64
   PubMed Web of Science ®Google Scholar
• Traish AM, Goldstein I, Kim NN. Testosterone and erectile function: from basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction. Eur Urol 2007;52:54–70
   PubMed Web of Science ®Google Scholar
• Martinez-Jabaloyas JM, Queipo-Zaragoza A, Pastor-Hernandez F, et al. Testosterone levels in men with erectile dysfunction. BJU Int 2006;97:1278–83
   PubMed Web of Science ®Google Scholar
• Campbell B, Leslie P, Campbell K. Age-related changes in testosterone and SHBG among Turkana males. Am J Hum Biol 2006;18:71–82
   PubMed Web of Science ®Google Scholar
• Campbell B, O'Rourke MT, Lipson SF. Salivary testosterone and body composition among Ariaal males. Am J Hum Biol 2003;15:697–708
   PubMed Web of Science ®Google Scholar
• Ongphiphadhanakul B, Rajatanavin R, Chailurkit L, et al. Serum testosterone and its relation to bone mineral density and body composition in normal males. Clin Endocrinol (Oxf) 1995;43:727–33
   PubMed Web of Science ®Google Scholar
• Jinrui H, Itoh N, Nitta T, et al. Changes in the salivary testosterone level in aged. Hinyokika Kiyo 1994;40:807–11
   PubMedGoogle Scholar
• Li JY, Li XY, Li M, et al. Decline of serum levels of free testosterone in aging healthy Chinese men. Aging Male 2005;8:203–6
   PubMedGoogle Scholar
• Kang YG, Bae CY, Kim S, et al. Age-related change in serum concentrations of testosterone in middle-aged Korean men. Aging Male 2003;6:8–12
   PubMedGoogle Scholar
• Spratt DI, Cox P, Orav J, et al. Reproductive axis suppression in acute illness is related to disease severity. J Clin Endocrinol Metab 1993;76:1548–54
   PubMed Web of Science ®Google Scholar
• Snyder PJ, Peachey H, Hannoush P, et al. Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J Clin Endocrinol Metab 1999;84:2647–53
   PubMed Web of Science ®Google Scholar
• Bhasin S, Woodhouse L, Casaburi R, et al. Testosterone dose-response relationships in healthy young men. Am J Physiol Endocrinol Metab 2001;281:E1172–81
   PubMed Web of Science ®Google Scholar
• Bhasin S, Woodhouse L, Casaburi R, et al. Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle. J Clin Endocrinol Metab 2005;90:678–88
   PubMed Web of Science ®Google Scholar
• Dicker A, Ryden M, Naslund E, et al. Effect of testosterone on lipolysis in human pre-adipocytes from different fat depots. Diabetologia 2004;47:420–8
   PubMed Web of Science ®Google Scholar
• Svartberg J, von Muhlen D, Schirmer H, et al. Association of endogenous testosterone with blood pressure and left ventricular mass in men. The Tromsø Study. Eur J Endocrinol 2004;150:65–71
   PubMed Web of Science ®Google Scholar
• Derby CA, Zilber S, Brambilla D, et al. Body mass index, waist circumference and waist to hip ratio and change in sex steroid hormones: the Massachusetts Male Ageing Study. Clin Endocrinol (Oxf) 2006;65:125–31
   PubMed Web of Science ®Google Scholar
• Tsai EC, Boyko EJ, Leonetti DL, et al. Low serum testosterone level as a predictor of increased visceral fat in Japanese-American men. Int J Obes Relat Metab Disord 2000;24:485–91
   PubMed Web of Science ®Google Scholar
• Nieschlag E, Lammers U, Freischem CW, et al. Reproductive functions in young fathers and grandfathers. J Clin Endocrinol Metab 1982;55:676–81
   PubMed Web of Science ®Google Scholar
• Feldman HA, Longcope C, Derby CA, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 2002;87:589–98
   PubMed Web of Science ®Google Scholar
• Barrett-Connor E, Goodman-Gruen D, Patay B. Endogenous sex hormones and cognitive function in older men. J Clin Endocrinol Metab 1999;84:3681–5
   PubMed Web of Science ®Google Scholar
• Aloisi AM, Aurilio C, Bachiocco V, et al. Endocrine consequences of opioid therapy. Psychoneuroendocrinology 2009;34:S162–8
   Google Scholar
• Aloisi AM, Pari G, Ceccarelli I, et al. Gender-related effects of chronic non-malignant pain and opioid therapy on plasma levels of macrophage migration inhibitory factor (MIF). Pain 2005;115:142–51
   PubMed Web of Science ®Google Scholar
• Aurilio C, Ceccarelli I, Pota V, et al. Endocrine and behavioural effects of transdermal buprenorphine in pain-suffering women of different reproductive ages. Endocr J 2011;58:1071–8
   PubMed Web of Science ®Google Scholar
• De Maddalena C, Bellini M, Berra M, et al. Opioid-induced hypogonadism: why and how to treat it. Pain Phys 2012;15:ES111–8
   Google Scholar
• Fraser LA, Morrison D, Morley-Forster P, et al. Oral opioids for chronic non-cancer pain: higher prevalence of hypogonadism in men than in women. Exp Clin Endocrinol Diabetes 2009;117:38–43
   PubMed Web of Science ®Google Scholar
• Basaria S, Travison TG, Alford D, et al. Effects of testosterone replacement in men with opioid-induced androgen deficiency: a randomized controlled trial. Pain 2015;156:280–8
   PubMed Web of Science ®Google Scholar
• Elliott JA, Horton E, Fibuch EE. The endocrine effects of long-term oral opioid therapy: a case report and review of the literature. J Opioid Manag 2011;7:145–54
   PubMedGoogle Scholar
• Davis S. Testosterone deficiency in women. J Reprod Med 2001;46:291–6
   PubMed Web of Science ®Google Scholar